CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 275 of 434 entries

View as:

Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA

Phase: N/A Priority: Normal

NCT ID: NCT00843284 Org: User:

Start: 09/30/06 End: 03/31/08 Due: 03/31/09

Evaluation of Atorvastatin Treatment on Carotid Plaque.

Phase: N/A Priority: Normal

NCT ID: NCT00343655 Org: User:

Start: 01/31/07 End: 08/31/07 Due: 08/31/08

Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement

Phase: N/A Priority: Normal

NCT ID: NCT00442546 Org: User:

Start: 05/31/07 End: 12/31/08 Due: 12/31/09

Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

Phase: N/A Priority: Normal

NCT ID: NCT01115855 Org: User:

Start: 07/31/10 End: 09/30/15 Due: 09/30/16

A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury

Phase: N/A Priority: Normal

NCT ID: NCT00407745 Org: User:

Start: 01/31/07 End: 02/28/11 Due: 02/28/12

A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol

Phase: N/A Priority: Normal

NCT ID: NCT00645424 Org: User:

Start: 12/31/03 End: 10/31/04 Due: 10/31/05

An fMRI Study Of Brain Response In Patients With Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT00760474 Org: User:

Start: 01/31/09 End: 03/31/11 Due: 03/31/12

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

Phase: N/A Priority: Normal

NCT ID: NCT00644982 Org: User:

Start: 10/31/02 End: 09/30/03 Due: 09/30/04

Once-A-Day Pregabalin For Partial Seizures

Phase: N/A Priority: Normal

NCT ID: NCT01262677 Org: User:

Start: 02/17/11 End: 08/01/12 Due: 08/01/13

A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT01247805 Org: User:

Start: 01/31/11 End: 02/28/11 Due: 02/28/12

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Phase: N/A Priority: Normal

NCT ID: NCT01720524 Org: User:

Start: 08/05/13 End: 09/28/20 Due: 09/28/21

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

Phase: N/A Priority: Normal

NCT ID: NCT00137397 Org: User:

Start: 11/30/04 End: 08/31/06 Due: 08/31/07

Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules

Phase: N/A Priority: Normal

NCT ID: NCT00821444 Org: User:

Start: 01/31/09 End: 03/31/09 Due: 03/31/10

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Phase: N/A Priority: Normal

NCT ID: NCT00139724 Org: User:

Start: 05/31/05 End: 10/31/06 Due: 10/31/07

A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)

Phase: N/A Priority: Normal

NCT ID: NCT00644709 Org: User:

Start: 09/30/03 End: 03/31/05 Due: 03/31/06

Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00139737 Org: User:

Start: 03/31/02 End: 06/30/09 Due: 06/30/10

Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure

Phase: N/A Priority: Normal

NCT ID: NCT00245609 Org: User:

Start: 01/31/06 End: 10/31/06 Due: 10/31/07

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

Phase: N/A Priority: Normal

NCT ID: NCT00874185 Org: User:

Start: 12/31/07 End: 05/31/08 Due: 05/31/09

Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

Phase: N/A Priority: Normal

NCT ID: NCT01302080 Org: User:

Start: 04/04/12 End: 09/09/20 Due: 09/09/21

Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).

Phase: N/A Priority: Normal

NCT ID: NCT00288639 Org: User:

Start: 12/31/05 End: 12/31/07 Due: 12/31/08

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00645268 Org: User:

Start: 12/31/02 End: 01/31/04 Due: 01/31/05

A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Phase: N/A Priority: Normal

NCT ID: NCT00644670 Org: User:

Start: 06/30/03 End: 03/31/04 Due: 03/31/05

Taste Test of a New Formulation of Sildenafil (Revatio)

Phase: N/A Priority: Normal

NCT ID: NCT00768573 Org: User:

Start: 01/31/08 End: 01/31/08 Due: 01/31/09

Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

Phase: N/A Priority: Normal

NCT ID: NCT00978341 Org: User:

Start: 02/28/07 End: 10/31/08 Due: 10/31/09

Evaluation of the Index of Sexual Life Questionnaire

Phase: N/A Priority: Normal

NCT ID: NCT00245596 Org: User:

Start: 10/31/05 End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA	NCT00843284	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-09-30	2008-03-31	2009-03-31	-	-	2025-07-14
Evaluation of Atorvastatin Treatment on Carotid Plaque.	NCT00343655	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-01-31	2007-08-31	2008-08-31	-	-	2025-07-14
Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement	NCT00442546	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-05-31	2008-12-31	2009-12-31	-	-	2025-07-14
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure	NCT01115855	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-07-31	2015-09-30	2016-09-30	-	-	2025-07-14
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury	NCT00407745	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-01-31	2011-02-28	2012-02-28	-	-	2025-07-14
A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol	NCT00645424	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-12-31	2004-10-31	2005-10-31	-	-	2025-07-14
An fMRI Study Of Brain Response In Patients With Fibromyalgia	NCT00760474	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-01-31	2011-03-31	2012-03-31	-	-	2025-07-14
A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression	NCT00644982	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-10-31	2003-09-30	2004-09-30	-	-	2025-07-14
Once-A-Day Pregabalin For Partial Seizures	NCT01262677	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-02-17	2012-08-01	2013-08-01	-	-	2025-07-14
A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions	NCT01247805	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-01-31	2011-02-28	2012-02-28	-	-	2025-07-14
A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn	NCT01720524	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2013-08-05	2020-09-28	2021-09-28	-	-	2025-07-14
A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder	NCT00137397	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-11-30	2006-08-31	2007-08-31	-	-	2025-07-14
Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules	NCT00821444	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-01-31	2009-03-31	2010-03-31	-	-	2025-07-14
Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet	NCT00139724	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-05-31	2006-10-31	2007-10-31	-	-	2025-07-14
A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)	NCT00644709	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-09-30	2005-03-31	2006-03-31	-	-	2025-07-14
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia	NCT00139737	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-03-31	2009-06-30	2010-06-30	-	-	2025-07-14
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure	NCT00245609	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-01-31	2006-10-31	2007-10-31	-	-	2025-07-14
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk	NCT00874185	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-12-31	2008-05-31	2009-05-31	-	-	2025-07-14
Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)	NCT01302080	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-04-04	2020-09-09	2021-09-09	-	-	2025-07-14
Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).	NCT00288639	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-12-31	2007-12-31	2008-12-31	-	-	2025-07-14
A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes	NCT00645268	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-12-31	2004-01-31	2005-01-31	-	-	2025-07-14
A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol	NCT00644670	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-06-30	2004-03-31	2005-03-31	-	-	2025-07-14
Taste Test of a New Formulation of Sildenafil (Revatio)	NCT00768573	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-01-31	2008-01-31	2009-01-31	-	-	2025-07-14
Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design	NCT00978341	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-02-28	2008-10-31	2009-10-31	-	-	2025-07-14
Evaluation of the Index of Sexual Life Questionnaire	NCT00245596	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-10-31	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance